Banner for leaf pages 2

Aliskiren (Tekturna)

Also known as Tekturna

Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.

Source: Wikipedia

Estimated Total Cost: $82.75 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed aliskiren to treat high blood pressure, coronary atherosclerosis, chronic kidney disease, and rabies.

Ajax-loader Loading...